Health concerns are still the primary motive for more than half of those who say they want to stop smoking in England, but cost is now a key factor for more than 1 in 4, finds an analysis of national survey responses, published in the open access journal BMJ Public Health.
Boston Scientific resumes PFA trial in new patient group after pausing enrollment
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Boston Scientific has resumed a
November 12, 2024